Back to search
FDAFDA · Food and drugs·Recall number D-0531-2025

TESTO-200, Testosterone Cypionate Inj. USP, 2000mg/10ml (200mg/ml), One 10ml multidose vial per carton, For intramuscular injection only, Rx Only, ADVANCED PHARMACEUTICAL TECHNOLOGY, INC., 132 South Central Avenue, Elmsford, NY 10523. NDC 57377-200-01

Published July 2, 2025 · Recall initiated: May 30, 2025

Summary

FDA records drug Class II recall D-0531-2025, published July 2, 2025 and initiated May 30, 2025. Recalling firm: Advanced Pharmaceutical Technology, Inc.; Status: Ongoing; Reported quantity: 26 vials; Lot: Lot P-24-1; Exp. 02/28/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without an Approved NDA/ANDA

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Advanced Pharmaceutical Technology, Inc.
Distributor
NY, NJ
Lot
Lot P-24-1; Exp. 02/28/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was TESTO-200, Testosterone Cypionate Inj. USP, 2000mg/10ml (200mg/ml), One 10ml multidose vial per carton, For intramuscular injection only, Rx Only, ADVANCED PHARMACEUTICAL TECHNOLOGY, INC., 132 South Central Avenue, Elmsford, NY 10523. NDC 57377-200-01 recalled?

Yes. FDA published recall D-0531-2025 on July 2, 2025. Reported hazard: Marketed Without an Approved NDA/ANDA

What should I do if I have this product?

Voluntary: Firm initiated · Letter